EurBee 2018
You are here > Programme | Abstract Submission

Abstract submission


The scientific committee welcomes contributions for oral communication, poster or video presentation.

Deadline Late poster submission: 15 April 2018

The submitted abstracts will be peer reviewed and evaluated based on:

  • Novelty and scientific quality.
  • Clarity of the aim and experimental design.
  • Relevance of the topic and the results.


A. General Instructions
  1. As only a limited number of oral presentations can be accepted, authors are requested to indicate whether they wish their abstract to be considered for:
    • oral presentation
    • poster presentation
  2. Abstracts must be in English and submitted on-line
  3. Notification of acceptance will be dispatched by e-mail.
  4. To allow efficient handling of the abstracts, the authors are requested to select a main topic.
  5. Presenting authors whose abstracts have been accepted must register for the meeting and pay the registration fees by 3O March 2018. Failure to do so will result in exclusion from the program and from the abstract book.
B. Abstract Format
  1. Abstract Format:
    • Abstract title: should be in capital letters
    • Authors: the names of the authors should be listed in the following order: Last name, First name, Department, Institution, City, Country.
    • Abstract body: the abstract body should contain maximum 300 Words.
  2. The use of tables, graphs, diagrams, images and embedded videos in the abstract submission is not allowed.
  3. Use standard abbreviations. Please explain special or unusual abbreviations the first time they appear.
  4. Abstract Main topics:

    Basic science

    • Neural reserve and synapthopathy
    • Brain plasticity experimental
    • Brain plasticity clinical and clinical physiopathology
    • Gene therapy, Regenerative medicine and tissue engineering
    • Neural greenwood function, pitch/place and stimulation strategy
    • Directional hearing
    • Auditory percept and development

    Diagnosis and genetics

    • Neonatal hearing screening
    • Neonatal and prelingual work-up incl imaging
    • Postlingual work-up incl imaging
    • Advances in genetic testing
    • Genetics and poor CI outcomes
    • Genetics and hearing preservation in CI

    CI children surgery and outcome

    • Pediatric outcome measures
    • Pediatric bilateral Cochlear Implant (simultaneous and sequential)
    • Eas-hybrid CI in children
    • Congenital inner ear malformations
    • Pediatric ABI
    • Pediatric Single Sided Deafness and CI
    • Surgical challenges and techniques in pediatric CI
    • Complications, non adherance, meningitis
    • Auditory neuropathy
    • Directional hearing

    CI adults surgery and outcome

    • Postlingual outcome measures
    • Hearing and structure preservation Eas-hybrid surgery
    • CI and Single Sided Deafness
    • Electode, insertion depth and stimulation choice
    • Surgical challenges (advanced otosclerosis, radical cavity, anatomical variations)
    • CI and tinnitus
    • Postlingual ABI
    • Vestibular implant
    • CI surgical challenges and techniques
    • Complications and management
    • Revision surgery
    • CI and genetherapy/regenerative medicine/drug delivery
    • Robotics
    • Technological innovation
    • Expanding indications
    • Fully implantable technologies (CI and AMEI)

    Active Middle ear implant and Bone conduction Implants

    • Consesnsus standardisation outcomes
    • AMEI in pediatric malformations and reconstructive surgery
    • AMEI performance (adults and children)
    • Indicationfield of MEI vs BCD
    • Single Sided Deafness and hearing aids/AMEI/BCD/CI
    • Complications of AMEI and BCI
    • Surgical challenges inAMEI and BCI
    • Pinna Reconstruction and implants
    • Skull base surgery and implants

    Rehabilitiation children

    • CI in Usher
    • CI in CMV
    • CI children multi handicap
    • Language development and Implants
    • CI in teenagers vs young adults
    • CI and music perception
    • Fitting in children
    • School and carreer development
    • Poor progressing child
    • Monitoring child progression
    • CI, AMEI, BCD and connectivity with listening devices

    Rehabilitation adult

    • Bimodal stimulation
    • Eas fitting
    • Remote and automatic fitting
    • Ageing cognition and CI
    • Adult implantation of congenital deafness
    • MRI and CI
    • Monitoring progress of CI rehabilitation
    • CI, AMEI, BCD and connectivity with listening devices (mobiles, streaming, ..)
    • CI, AMEI,BCD and specific working and leisture adaptations incl swiming
    • CI and family, partners and friends

    Objectiove measures

    • Brain imaging and CI
    • Auditory evoked potentials
    • Intra-operative testing
    • Intra-operative imaging
    • CI integrity testing
    • AMEI and CI per and postop implant efficacy assessment
    • Pre-per and post implant imaging and computer assited surgery

    Ethics economics and costs new technology

    • Device reliability
    • Device history
    • Reimbursement criteria
    • New technology assessment
    • Robotics
    • Quality of life
    • Auditory Implants in middle and poor income countries
    • Building an auditory implant centre
    • Quality assessment of auditory implant centres
    • ICD11 and SNOMED classification of severe hearing loss and auditory implants


C. Abstract Timeline
Abstract submission deadline: 5 February 2018
Notification of acceptance: 28 February 2018

Abstract submission

↑ Top
Copyright © 2018 Semico nvPowered by Mintyfresh Software Architects